Literature DB >> 16618951

Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

Rebecca Smith-Bindman1, Diana L Miglioretti, Nicole Lurie, Linn Abraham, Rachel Ballard Barbash, Jodi Strzelczyk, Mark Dignan, William E Barlow, Cherry M Beasley, Karla Kerlikowske.   

Abstract

BACKGROUND: Reasons for persistent differences in breast cancer mortality rates among various racial and ethnic groups have been difficult to ascertain.
OBJECTIVE: To determine reasons for disparities in breast cancer outcomes across racial and ethnic groups.
DESIGN: Prospective cohort.
SETTING: The authors pooled data from 7 mammography registries that participate in the National Cancer Institute-funded Breast Cancer Surveillance Consortium. Cancer diagnoses were ascertained through linkage with pathology databases; Surveillance, Epidemiology, and End Results programs; and state tumor registries. PARTICIPANTS: 1,010,515 women 40 years of age and older who had at least 1 mammogram between 1996 and 2002; 17,558 of these women had diagnosed breast cancer. MEASUREMENTS: Patterns of mammography and the probability of inadequate mammography screening were examined. The authors evaluated whether overall and advanced cancer rates were similar across racial and ethnic groups and whether these rates were affected by the use of mammography.
RESULTS: African-American, Hispanic, Asian, and Native American women were more likely than white women to have received inadequate mammographic screening (relative risk, 1.2 [95% CI, 1.2 to 1.2], 1.3 [CI, 1.2 to 1.3], 1.4 [CI, 1.3 to 1.4], and 1.2 [CI, 1.1 to 1.2] respectively). African-American women were more likely than white, Asian, and Native American women to have large, advanced-stage, high-grade, and lymph node-positive tumors of the breast. The observed differences in advanced cancer rates between African American and white women were attenuated or eliminated after the cohort was stratified by screening history. Among women who were previously screened at intervals of 4 to 41 months, African-American women were no more likely to have large, advanced-stage tumors or lymph node involvement than white women with the same screening history. African-American women had higher rates of high-grade tumors than white women regardless of screening history. The lower rates of advanced cancer among Asian and Native American women persisted when the cohort was stratified by mammography history. LIMITATIONS: Results are based on a cohort of women who had received mammographic evaluations.
CONCLUSIONS: African-American women are less likely to receive adequate mammographic screening than white women, which may explain the higher prevalence of advanced breast tumors among African-American women. Tumor characteristics may also contribute to differences in cancer outcomes because African-American women have higher-grade tumors than white women regardless of screening. These results suggest that adherence to recommended mammography screening intervals may reduce breast cancer mortality rates.

Entities:  

Mesh:

Year:  2006        PMID: 16618951     DOI: 10.7326/0003-4819-144-8-200604180-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  136 in total

1.  Breast cancer screening trends in the United States and ethnicity.

Authors:  Patricia Y Miranda; Wassim Tarraf; Patricia González; Michelle Johnson-Jennings; Hector M González
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

2.  Use of annual mammography among older women with ductal carcinoma in situ.

Authors:  Phyllis Brawarsky; Bridget A Neville; Garrett M Fitzmaurice; Michael J Hassett; Jennifer S Haas
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

3.  Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women.

Authors:  Matthew P Banegas; Christopher I Li
Journal:  Breast Cancer Res Treat       Date:  2012-07-08       Impact factor: 4.872

4.  Perceived risk for breast cancer and its relationship to mammography in Blacks, Hispanics, and Whites.

Authors:  Heather Orom; Marc T Kiviniemi; Vickie L Shavers; Levi Ross; Willie Underwood
Journal:  J Behav Med       Date:  2012-07-08

5.  Adapting a Cancer Literacy Measure for Use Among Navajo Women.

Authors:  Kathleen J Yost; Mark C Bauer; Lydia P Buki; Martha Austin-Garrison; Linda V Garcia; Christine A Hughes; Christi A Patten
Journal:  J Transcult Nurs       Date:  2016-02-15       Impact factor: 1.959

Review 6.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

7.  The role of social capital in African-American women's use of mammography.

Authors:  Lorraine Dean; S V Subramanian; David R Williams; Katrina Armstrong; Camille Zubrinsky Charles; Ichiro Kawachi
Journal:  Soc Sci Med       Date:  2013-12-13       Impact factor: 4.634

8.  A comparative analysis of breast cancer stage between women enrolled in the National Breast and Cervical Cancer Early Detection Program and women not participating in the program.

Authors:  Manxia Wu; Harland Austin; Christie R Eheman; Zachary Myles; Jacqueline Miller; Janet Royalty; A Blythe Ryerson
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

9.  Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening.

Authors:  Ryan A Denu
Journal:  JAMA Oncol       Date:  2018-06-01       Impact factor: 31.777

10.  The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.

Authors:  Jennifer L Beebe-Dimmer; Terrance L Albrecht; Tara E Baird; Julie J Ruterbusch; Theresa Hastert; Felicity W K Harper; Michael S Simon; Judith Abrams; Kendra L Schwartz; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-27       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.